Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.76)
# 3,829
Out of 4,876 analysts
310
Total ratings
22.22%
Success rate
-30.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Reiterates: Buy | $12 | $0.98 | +1,124.49% | 24 | Jun 25, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $115 | $65.35 | +75.98% | 13 | Jun 16, 2025 | |
| ARTV Artiva Biotherapeutics | Assumes: Buy | $12 | $1.47 | +716.33% | 1 | Jun 11, 2025 | |
| AGEN Agenus | Upgrades: Buy | $25 | $4.76 | +425.21% | 18 | Jun 4, 2025 | |
| ANAB AnaptysBio | Upgrades: Buy | $22 → $38 | $22.47 | +69.11% | 10 | Jun 4, 2025 | |
| RAPT RAPT Therapeutics | Assumes: Buy | $48 | $8.43 | +469.40% | 1 | May 22, 2025 | |
| SABS SAB Biotherapeutics | Assumes: Buy | $10 | $1.73 | +478.03% | 1 | May 14, 2025 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $30 | $4.62 | +549.35% | 20 | Apr 28, 2025 | |
| SANA Sana Biotechnology | Reiterates: Buy | $11 | $2.81 | +291.46% | 11 | Apr 24, 2025 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $32 | $2.96 | +981.08% | 14 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $7.97 | +3,413.17% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $14.54 | +147.59% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.00 | +700.00% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.44 | +733.33% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.99 | +903.34% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.20 | +1,483.33% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.66 | +984.34% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.74 | +1,791.89% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.88 | +695.91% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.66 | +657.35% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $7.45 | +369.80% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.45 | +566.67% | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.49 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.49 | +628.60% | 9 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $7.95 | +201.89% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $33.47 | +73.29% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.61 | +2,852.76% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.34 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $18.00 | +111.11% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.30 | +1,334.78% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.19 | - | 1 | Apr 25, 2024 |
Femasys
Jun 25, 2025
Reiterates: Buy
Price Target: $12
Current: $0.98
Upside: +1,124.49%
Arcellx
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $65.35
Upside: +75.98%
Artiva Biotherapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $1.47
Upside: +716.33%
Agenus
Jun 4, 2025
Upgrades: Buy
Price Target: $25
Current: $4.76
Upside: +425.21%
AnaptysBio
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $22.47
Upside: +69.11%
RAPT Therapeutics
May 22, 2025
Assumes: Buy
Price Target: $48
Current: $8.43
Upside: +469.40%
SAB Biotherapeutics
May 14, 2025
Assumes: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Olema Pharmaceuticals
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $4.62
Upside: +549.35%
Sana Biotechnology
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
BriaCell Therapeutics
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $2.96
Upside: +981.08%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $7.97
Upside: +3,413.17%
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $14.54
Upside: +147.59%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.00
Upside: +700.00%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $1.44
Upside: +733.33%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.99
Upside: +903.34%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.20
Upside: +1,483.33%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.66
Upside: +984.34%
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $0.74
Upside: +1,791.89%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.88
Upside: +695.91%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +657.35%
Mar 18, 2025
Reiterates: Buy
Price Target: $35
Current: $7.45
Upside: +369.80%
Mar 17, 2025
Reiterates: Buy
Price Target: $3
Current: $0.45
Upside: +566.67%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $40
Current: $5.49
Upside: +628.60%
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $7.95
Upside: +201.89%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $33.47
Upside: +73.29%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.61
Upside: +2,852.76%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.34
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $18.00
Upside: +111.11%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.30
Upside: +1,334.78%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.19
Upside: -